Advertisement
HPB| Volume 157, ISSUE 2, P202-203, February 2015

Commentary on “Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?”

      The Associated Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) approach for staged hepatic resection in patients with a small functional liver remnant has captivated the attention of hepatobiliary pancreatic (HPB) surgery since initially being reported in 2012.
      • Schnitzbauer A.A.
      • Lang S.A.
      • Goessmann H.
      • et al.
      Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.
      The strategy to consolidate a complex operative therapy into a shorter, time-framed, staged resection based on the liver's remarkable regenerative capacity appeals to both patient and surgeon. ALPPS entry into the realm of HPB surgery has been striking, alluring to some, affronting to others, and undoubtedly controversial. Patients, however, only grasp that ALPPS provides a quicker solution for staged operations of their hepatic metastases with assumedly similar outcomes. Surgeons' perceptions and responsibilities are far broader and demand that the enthusiasm for a novel approach be tempered by rigorous assessment and appropriately defined indications. To date, the indications for ALPPS are still evolving, and the associated risks have been considered formidable by many surgeons. As with any novel operative approach, technical refinement and outcomes analysis of ALPPS are critical for the HPB community at large to judge its true value.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schnitzbauer A.A.
        • Lang S.A.
        • Goessmann H.
        • et al.
        Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.
        Ann Surg. 2012; 255: 405-414
        • Hernandez-Alejandro R
        • Bertens KA
        • Pineda-Solis K.
        • et al.
        Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?.
        Surgery. 2015; 157: 194-201
        • Chun Y.S.
        • Vauthey J.N.
        • Ribero D.
        • et al.
        Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and Survival.
        J Gastrointest Surg. 2007; 11: 1498-1505
        • Ielpo B.
        • Caruso R.
        • Ferri V.
        • et al.
        ALPPS procedure: our experience and state of the art.
        Hepatogastroenterology. 2013; 60: 2069-2075
        • Schadde E.
        • Ardiles V.
        • Slankamenac K.
        • et al.
        ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.
        World J Surg. 2014; 38: 1510-1519

      Linked Article